Health-Related Quality of Life in Patients with Metastatic Basal Cell Carcinoma Treated with Cemiplimab: Analysis of a Phase 2 Open-Label Clinical Trial. J of Skin. 2024;8(1):s337. doi:10.25251/skin.8.supp.337